Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

2 Beaten-Down Stocks That Are Great Buys on the Dip
2 Beaten-Down Stocks That Are Great Buys on the Dip

Even when equities are volatile, investors can find great stocks to buy. And the rules for investing in the current environment aren't that different, at least for those focused on the long game

EQS-News: RHÖN-KLINIKUM AG holds steady course in first quarter of 2025 – outlook confirmed
EQS-News: RHÖN-KLINIKUM AG holds steady course in first quarter of 2025 – outlook confirmed
EQS-News: RHÖN-KLINIKUM AG holds steady course in first quarter of 2025 – outlook confirmed
EQS-News: Change of President and CEO at Carl Zeiss Meditec AG
EQS-News: Change of President and CEO at Carl Zeiss Meditec AG
EQS-News: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
EQS-News: Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments
EQS-News: Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments
EQS-News: Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments
EQS-News: Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment
EQS-News: Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment
EQS-News: Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment
EQS-News: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
EQS-News: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now
Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now

One great thing about a crash or downturn in the markets is that it can allow you to go bargain hunting fairly easily. Many stocks have been falling this year, and if you're a dividend investor, you

EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025
EQS-News: Evotec SE to announce results for the first quarter 2025 on 6 May 2025
EQS-News: Evotec SE to announce results for the first quarter 2025 on 6 May 2025
EQS-News: Evotec SE to announce results for the first quarter 2025 on 6 May 2025
EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition
EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition
EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition
EQS-News: Evotec announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb
EQS-News: Evotec announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb
EQS-News: Evotec announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb
EQS-Adhoc: STRATEC REPORTS PRELIMINARY BUSINESS RESULTS FOR 2024, PROVIDES GUIDANCE FOR 2025, AND POSTPONES 2024 ANNUAL REPORT
EQS-Adhoc: STRATEC REPORTS PRELIMINARY BUSINESS RESULTS FOR 2024, PROVIDES GUIDANCE FOR 2025, AND POSTPONES 2024 ANNUAL REPORT
EQS-Adhoc: STRATEC REPORTS PRELIMINARY BUSINESS RESULTS FOR 2024, PROVIDES GUIDANCE FOR 2025, AND POSTPONES 2024 ANNUAL REPORT
EQS-News: Evotec SE unveils new strategy and provides 2025 guidance bolstered by strong Q4 2024 results
EQS-News: Evotec SE unveils new strategy and provides 2025 guidance bolstered by strong Q4 2024 results
EQS-News: Evotec SE unveils new strategy and provides 2025 guidance bolstered by strong Q4 2024 results
EQS-News: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter
EQS-News: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter
EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development
EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings
EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings
EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings
EQS-News: Evotec SE to announce results for financial year 2024 on 17 April 2025
EQS-News: Evotec SE to announce results for financial year 2024 on 17 April 2025
EQS-News: Evotec SE to announce results for financial year 2024 on 17 April 2025
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

The Dow Jones Industrial Average (DJINDICES: ^DJI) fell sharply after the U.S. released a new tariff program. Does that open up some opportunities for investors who like high-yield stocks? A quick

EQS-News: Sartorius to acquire microtissue business MatTek from Swedish BICO AB : https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: Sartorius to acquire microtissue business MatTek from Swedish BICO AB
EQS-News: Sartorius to acquire microtissue business MatTek from Swedish BICO AB
2 Beaten-Down Stocks to Buy and Hold for a Decade
2 Beaten-Down Stocks to Buy and Hold for a Decade

Recent market volatility notwithstanding, equities generally deliver solid returns over long periods, like a decade. The key is to purchase shares of robust companies, occasionally adding more, and

EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement  of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-News: First ISCC Plus certifications pave the way for renewable plastics at Sartorius: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: First ISCC Plus certifications pave the way for renewable plastics at Sartorius
EQS-News: First ISCC Plus certifications pave the way for renewable plastics at Sartorius
EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer
EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer
EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer